Canopy Biosciences LLC, of St. Louis, which provides gene editing and gene expression products and services, said it acquired Zellkraftwerk GmbH, of Leipzig, Germany, which offers multiplex cytometry. Concurrent with the acquisition, Canopy closed a strategic investment from Ampersand Capital Partners. Details were not disclosed.